September 3, 2026
Aurora Cannabis formally rejected Curaleaf's hostile takeover bid, sending both stocks down sharply.
What happened
Aurora Cannabis pushed back against an unsolicited offer from Curaleaf. The news hit both sides hard: ACB fell 3.5 percent and CURLF fell 5.3 percent. The hostile bid targeted roughly 500 billion dollars in market value.
Why it matters
In a hostile deal, the acquirer often sees its stock drop if shareholders fear it will overpay or take on too much debt. The target can drop if the market thinks the bid will fail and the standalone business is weaker. The sharp moves suggest investors see low odds of a deal and rising costs for both sides as the fight drags on.
The case against
A merger could create scale in a fragmented cannabis market, driving cost savings and pricing power. Regulatory hurdles are the stated risk, but a successful deal would still lift the target and may eventually reward the acquirer.
What settles it
Whether another bidder emerges or Curaleaf raises its offer, which would signal the board sees hidden value.